MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $125,000 | -59.4% | 30,550 | -37.1% | 0.01% | -61.5% |
| Q3 2016 | $308,000 | +17.6% | 48,550 | 0.0% | 0.01% | +18.2% |
| Q2 2016 | $262,000 | -35.5% | 48,550 | 0.0% | 0.01% | -35.3% |
| Q1 2016 | $406,000 | +5.7% | 48,550 | 0.0% | 0.02% | +13.3% |
| Q4 2015 | $384,000 | -34.0% | 48,550 | -29.0% | 0.02% | -34.8% |
| Q3 2015 | $582,000 | -31.1% | 68,365 | 0.0% | 0.02% | -17.9% |
| Q2 2015 | $845,000 | +4.1% | 68,365 | 0.0% | 0.03% | +7.7% |
| Q1 2015 | $812,000 | +5.0% | 68,365 | 0.0% | 0.03% | +4.0% |
| Q4 2014 | $773,000 | – | 68,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
| B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
| Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
| COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
| Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
| Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
| Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
| EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
| TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |